US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
GB0121980D0
(en)
|
2001-09-11 |
2001-10-31 |
Cathnet Science Holding As |
Expandable stent
|
US7147656B2
(en)
|
2001-12-03 |
2006-12-12 |
Xtent, Inc. |
Apparatus and methods for delivery of braided prostheses
|
US7351255B2
(en)
|
2001-12-03 |
2008-04-01 |
Xtent, Inc. |
Stent delivery apparatus and method
|
US8080048B2
(en)
|
2001-12-03 |
2011-12-20 |
Xtent, Inc. |
Stent delivery for bifurcated vessels
|
US20030135266A1
(en)
|
2001-12-03 |
2003-07-17 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US7137993B2
(en)
|
2001-12-03 |
2006-11-21 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US7294146B2
(en)
|
2001-12-03 |
2007-11-13 |
Xtent, Inc. |
Apparatus and methods for delivery of variable length stents
|
US7309350B2
(en)
|
2001-12-03 |
2007-12-18 |
Xtent, Inc. |
Apparatus and methods for deployment of vascular prostheses
|
US7182779B2
(en)
|
2001-12-03 |
2007-02-27 |
Xtent, Inc. |
Apparatus and methods for positioning prostheses for deployment from a catheter
|
US20040186551A1
(en)
|
2003-01-17 |
2004-09-23 |
Xtent, Inc. |
Multiple independent nested stent structures and methods for their preparation and deployment
|
US7892273B2
(en)
|
2001-12-03 |
2011-02-22 |
Xtent, Inc. |
Custom length stent apparatus
|
US7084153B2
(en)
*
|
2002-04-12 |
2006-08-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments comprising steroids and a novel anticholinergic
|
US7241308B2
(en)
*
|
2003-06-09 |
2007-07-10 |
Xtent, Inc. |
Stent deployment systems and methods
|
US7553324B2
(en)
*
|
2003-10-14 |
2009-06-30 |
Xtent, Inc. |
Fixed stent delivery devices and methods
|
US7220755B2
(en)
*
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
US7326236B2
(en)
|
2003-12-23 |
2008-02-05 |
Xtent, Inc. |
Devices and methods for controlling and indicating the length of an interventional element
|
ATE418559T1
(de)
*
|
2004-03-01 |
2009-01-15 |
Terumo Corp |
Verfahren zur herstellung von o-alkylierten rapamycinderivaten
|
US7323006B2
(en)
|
2004-03-30 |
2008-01-29 |
Xtent, Inc. |
Rapid exchange interventional devices and methods
|
US20050288766A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Xtent, Inc. |
Devices and methods for controlling expandable prostheses during deployment
|
US8317859B2
(en)
|
2004-06-28 |
2012-11-27 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US20060034884A1
(en)
*
|
2004-08-10 |
2006-02-16 |
Stenzel Eric B |
Coated medical device having an increased coating surface area
|
US7901451B2
(en)
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
US8221824B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Boston Scientific Scimed, Inc. |
Deforming surface of drug eluting coating to alter drug release profile of a medical device
|
US7402168B2
(en)
*
|
2005-04-11 |
2008-07-22 |
Xtent, Inc. |
Custom-length stent delivery system with independently operable expansion elements
|
WO2007011707A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Polymer coatings containing drug powder of controlled morphology
|
WO2007011708A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
US7622477B2
(en)
*
|
2006-02-28 |
2009-11-24 |
Cordis Corporation |
Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
|
US8652198B2
(en)
|
2006-03-20 |
2014-02-18 |
J.W. Medical Systems Ltd. |
Apparatus and methods for deployment of linked prosthetic segments
|
PL2019657T3
(pl)
|
2006-04-26 |
2015-10-30 |
Micell Technologies Inc |
Powłoki zawierające wiele leków
|
US20070281117A1
(en)
|
2006-06-02 |
2007-12-06 |
Xtent, Inc. |
Use of plasma in formation of biodegradable stent coating
|
US20080269865A1
(en)
*
|
2006-08-07 |
2008-10-30 |
Xtent, Inc. |
Custom Length Stent Apparatus
|
MX2009001857A
(es)
*
|
2006-08-22 |
2009-03-02 |
Novartis Ag |
Tratamiento de trastornos fibrosantes.
|
US10695327B2
(en)
|
2006-09-13 |
2020-06-30 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US8088789B2
(en)
*
|
2006-09-13 |
2012-01-03 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
EP2702993B1
(en)
|
2006-09-13 |
2017-12-06 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US20080097591A1
(en)
*
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
US20080103584A1
(en)
*
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
CN101522691B
(zh)
*
|
2006-11-27 |
2012-08-22 |
泰尔茂株式会社 |
O-烷基化雷帕霉素衍生物的制备方法及o-烷基化雷帕霉素衍生物
|
CA2679712C
(en)
|
2007-01-08 |
2016-11-15 |
Micell Technologies, Inc. |
Stents having biodegradable layers
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
US20080199510A1
(en)
|
2007-02-20 |
2008-08-21 |
Xtent, Inc. |
Thermo-mechanically controlled implants and methods of use
|
US9888924B2
(en)
|
2007-03-06 |
2018-02-13 |
Covidien Lp |
Wound closure material
|
US8486132B2
(en)
|
2007-03-22 |
2013-07-16 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
JP5693228B2
(ja)
*
|
2007-11-14 |
2015-04-01 |
バイオセンサーズ インターナショナル グループ、リミテッド |
自動被覆装置および方法
|
US9101503B2
(en)
|
2008-03-06 |
2015-08-11 |
J.W. Medical Systems Ltd. |
Apparatus having variable strut length and methods of use
|
US20110098241A1
(en)
*
|
2008-04-14 |
2011-04-28 |
Poniard Pharmaceuticals, Inc. |
Rapamycin analogs as anti-cancer agents
|
CN102083397B
(zh)
|
2008-04-17 |
2013-12-25 |
米歇尔技术公司 |
具有生物可吸收层的支架
|
US20100055145A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Biosensors International Group |
Stent coatings for reducing late stent thrombosis
|
CN102215780B
(zh)
|
2008-09-25 |
2015-10-14 |
高级分支系统股份有限公司 |
部分压接支架
|
US8795347B2
(en)
|
2008-09-25 |
2014-08-05 |
Advanced Bifurcation Systems, Inc. |
Methods and systems for treating a bifurcation with provisional side branch stenting
|
US8769796B2
(en)
|
2008-09-25 |
2014-07-08 |
Advanced Bifurcation Systems, Inc. |
Selective stent crimping
|
US8821562B2
(en)
|
2008-09-25 |
2014-09-02 |
Advanced Bifurcation Systems, Inc. |
Partially crimped stent
|
US11298252B2
(en)
|
2008-09-25 |
2022-04-12 |
Advanced Bifurcation Systems Inc. |
Stent alignment during treatment of a bifurcation
|
CN104042612A
(zh)
|
2008-11-11 |
2014-09-17 |
得克萨斯大学体系董事会 |
哺乳动物雷帕霉素靶蛋白的抑制
|
US9981072B2
(en)
|
2009-04-01 |
2018-05-29 |
Micell Technologies, Inc. |
Coated stents
|
EP2453834A4
(en)
|
2009-07-16 |
2014-04-16 |
Micell Technologies Inc |
MEDICAL DEVICE DISPENSING MEDICINE
|
US8460745B2
(en)
*
|
2009-09-20 |
2013-06-11 |
Medtronic Vascular, Inc. |
Apparatus and methods for loading a drug eluting medical device
|
US9283211B1
(en)
|
2009-11-11 |
2016-03-15 |
Rapamycin Holdings, Llc |
Oral rapamycin preparation and use for stomatitis
|
EP2531140B1
(en)
|
2010-02-02 |
2017-11-01 |
Micell Technologies, Inc. |
Stent and stent delivery system with improved deliverability
|
WO2011119883A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
Stent alignment during treatment of a bifurcation
|
CA2794080A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
System and methods for treating a bifurcation
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
US10232092B2
(en)
|
2010-04-22 |
2019-03-19 |
Micell Technologies, Inc. |
Stents and other devices having extracellular matrix coating
|
CA2805631C
(en)
|
2010-07-16 |
2018-07-31 |
Micell Technologies, Inc. |
Drug delivery medical device
|
WO2012017449A1
(en)
*
|
2010-08-04 |
2012-02-09 |
Meril Life Sciences Pvt. Ltd |
Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties"
|
US8632846B2
(en)
*
|
2010-09-17 |
2014-01-21 |
Medtronic Vascular, Inc. |
Apparatus and methods for loading a drug eluting medical device
|
WO2012081429A1
(ja)
|
2010-12-16 |
2012-06-21 |
住友精化株式会社 |
擬ポリロタキサンの製造方法
|
EP2653482B1
(en)
|
2010-12-16 |
2015-09-30 |
Sumitomo Seika Chemicals Co. Ltd. |
Method for producing pseudopolyrotaxane
|
EP2653480B1
(en)
*
|
2010-12-16 |
2016-08-10 |
Sumitomo Seika Chemicals Co. Ltd. |
Method for producing refined polyrotaxane
|
JP6013191B2
(ja)
|
2010-12-16 |
2016-10-25 |
住友精化株式会社 |
擬ポリロタキサン水性分散体の製造方法
|
WO2012109382A2
(en)
|
2011-02-08 |
2012-08-16 |
Advanced Bifurcation Systems, Inc. |
Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
|
CA2826769A1
(en)
|
2011-02-08 |
2012-08-16 |
Advanced Bifurcation Systems, Inc. |
System and methods for treating a bifurcation with a fully crimped stent
|
ES2552468T3
(es)
*
|
2011-03-14 |
2015-11-30 |
Sumitomo Seika Chemicals Co. Ltd. |
Método de producción de un polirrotaxano hidrófilo modificado pulverizado
|
ES2620756T3
(es)
*
|
2011-03-14 |
2017-06-29 |
Sumitomo Seika Chemicals Co., Ltd. |
Composición de polirotaxano
|
CN103415537B
(zh)
*
|
2011-03-14 |
2016-06-22 |
住友精化株式会社 |
亲水性改性聚轮烷的制造方法
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
EP2589383A1
(en)
*
|
2011-11-06 |
2013-05-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin |
FKBP subtype-specific rapamycin analogue for use in treatment of diseases
|
JP2015512371A
(ja)
|
2012-03-23 |
2015-04-27 |
ザ・ユニバーシティ・オブ・クイーンズランド |
免疫調節性作用物質およびその使用
|
US20150094463A1
(en)
*
|
2012-03-30 |
2015-04-02 |
Ube Industries, Ltd. |
Hydroxyalkylated polyrotaxane production method
|
US9364273B2
(en)
|
2012-08-15 |
2016-06-14 |
DePuy Synthes Products, Inc. |
Drug eluting surgical screw
|
US10172796B2
(en)
|
2012-12-03 |
2019-01-08 |
Manli International Ltd. |
Use of umirolimus and its derivatives for treating cancer
|
ES2645951T3
(es)
*
|
2013-01-22 |
2017-12-11 |
Biosensors International Group, Ltd. |
Síntesis a baja temperatura de derivados de rapamicina
|
EP2967803B1
(en)
*
|
2013-03-12 |
2023-12-27 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
US20160030401A1
(en)
|
2013-03-13 |
2016-02-04 |
The Board Of Regents Of The University Of Texas System |
Use of mtor inhibitors for prevention of intestinal polyp growth and cancer
|
WO2014145780A1
(en)
|
2013-03-15 |
2014-09-18 |
Biosensors International Group, Ltd. |
Purification of rapamycin derivatives
|
WO2014186532A1
(en)
|
2013-05-15 |
2014-11-20 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
US20150073998A1
(en)
|
2013-09-09 |
2015-03-12 |
Apple Inc. |
Use of a Biometric Image in Online Commerce
|
EA201690987A1
(ru)
|
2013-11-13 |
2016-10-31 |
Новартис Аг |
Низкодозовые иммуностимулирующие ингибиторы mtor и их применения
|
CA2931684C
(en)
|
2013-12-19 |
2024-02-20 |
Novartis Ag |
Human mesothelin chimeric antigen receptors and uses thereof
|
US10287354B2
(en)
|
2013-12-20 |
2019-05-14 |
Novartis Ag |
Regulatable chimeric antigen receptor
|
AU2014373683B2
(en)
|
2013-12-31 |
2020-05-07 |
Rapamycin Holdings, Llc |
Oral rapamycin nanoparticle preparations and use
|
US9700544B2
(en)
|
2013-12-31 |
2017-07-11 |
Neal K Vail |
Oral rapamycin nanoparticle preparations
|
EP3811970A1
(en)
|
2014-03-15 |
2021-04-28 |
Novartis AG |
Regulatable chimeric antigen receptor
|
WO2015142675A2
(en)
|
2014-03-15 |
2015-09-24 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor
|
CA2940671A1
(en)
|
2014-04-07 |
2015-10-15 |
Novartis Ag |
Treatment of cancer using anti-cd19 chimeric antigen receptor
|
JP6300926B2
(ja)
*
|
2014-07-08 |
2018-03-28 |
国立大学法人大阪大学 |
自己修復性を有する高分子材料及びその製造方法
|
SG10201913765YA
(en)
|
2014-07-21 |
2020-03-30 |
Novartis Ag |
Treatment of cancer using a cd33 chimeric antigen receptor
|
EP3193915A1
(en)
|
2014-07-21 |
2017-07-26 |
Novartis AG |
Combinations of low, immune enhancing. doses of mtor inhibitors and cars
|
US11542488B2
(en)
|
2014-07-21 |
2023-01-03 |
Novartis Ag |
Sortase synthesized chimeric antigen receptors
|
EP4205749A1
(en)
|
2014-07-31 |
2023-07-05 |
Novartis AG |
Subset-optimized chimeric antigen receptor-containing cells
|
WO2016025880A1
(en)
|
2014-08-14 |
2016-02-18 |
Novartis Ag |
Treatment of cancer using gfr alpha-4 chimeric antigen receptor
|
DK3183268T3
(da)
|
2014-08-19 |
2020-05-11 |
Univ Pennsylvania |
Behandling af cancer ved anvendelse af en cd123-kimær antigenreceptor
|
CN107073066B
(zh)
|
2014-09-11 |
2021-09-17 |
加利福尼亚大学董事会 |
mTORC1抑制剂
|
CN114621969A
(zh)
|
2014-09-17 |
2022-06-14 |
诺华股份有限公司 |
用于过继免疫疗法的具有嵌合受体的靶向细胞毒性细胞
|
SG11201702895SA
(en)
|
2014-10-08 |
2017-05-30 |
Novartis Ag |
Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof
|
US20180334490A1
(en)
|
2014-12-03 |
2018-11-22 |
Qilong H. Wu |
Methods for b cell preconditioning in car therapy
|
US11161907B2
(en)
|
2015-02-02 |
2021-11-02 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
ES2876974T3
(es)
|
2015-04-07 |
2021-11-15 |
Novartis Ag |
Combinación de terapia con receptor de antígeno quimérico y derivados de amino pirimidina
|
AU2016249005B2
(en)
|
2015-04-17 |
2022-06-16 |
Novartis Ag |
Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells
|
WO2016172583A1
(en)
|
2015-04-23 |
2016-10-27 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
|
US10576076B2
(en)
|
2015-05-20 |
2020-03-03 |
Novartis Ag |
Pharmaceutical combination of everolimus with dactolisib
|
EP3325504A1
(en)
|
2015-07-21 |
2018-05-30 |
Novartis AG |
Methods for improving the efficacy and expansion of immune cells
|
KR20180080230A
(ko)
|
2015-11-11 |
2018-07-11 |
노파르티스 아게 |
미오스타틴 길항제의 용도, 이들을 함유하는 조합물 및 그의 용도
|
AU2017225733A1
(en)
|
2016-03-04 |
2018-09-27 |
Novartis Ag |
Cells expressing multiple chimeric antigen receptor (CAR) molecules and uses therefore
|
US10525083B2
(en)
|
2016-10-07 |
2020-01-07 |
Novartis Ag |
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
|
KR20190089005A
(ko)
|
2016-11-23 |
2019-07-29 |
노파르티스 아게 |
에베롤리무스, 닥톨리십 또는 둘 다를 사용하여 면역 반응을 증진시키는 방법
|
US20200055948A1
(en)
|
2017-04-28 |
2020-02-20 |
Novartis Ag |
Cells expressing a bcma-targeting chimeric antigen receptor, and combination therapy with a gamma secretase inhibitor
|
US20210154372A1
(en)
|
2017-05-15 |
2021-05-27 |
C.R. Bard, Inc. |
Medical device with drug-eluting coating and intermediate layer
|
US10596165B2
(en)
|
2018-02-12 |
2020-03-24 |
resTORbio, Inc. |
Combination therapies
|
WO2019210153A1
(en)
|
2018-04-27 |
2019-10-31 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
IL278335B1
(en)
|
2018-05-01 |
2024-05-01 |
Revolution Medicines Inc |
C26-linked rapamycin analogs as MTOR inhibitors
|
WO2019213282A1
(en)
|
2018-05-01 |
2019-11-07 |
Novartis Ag |
Biomarkers for evaluating car-t cells to predict clinical outcome
|
ES2945560T3
(es)
|
2018-05-01 |
2023-07-04 |
Revolution Medicines Inc |
Análogos de rapamicina unidos en C40, C28 y C-32 como inhibidores de mTOR
|
SG11202012447YA
(en)
|
2018-06-15 |
2021-01-28 |
Navitor Pharm Inc |
Rapamycin analogs and uses thereof
|
JP7262581B2
(ja)
|
2018-11-14 |
2023-04-21 |
ルトニックス,インコーポレーテッド |
改質されたデバイス表面に薬物溶出コーティングを有する医療用デバイス
|
WO2020209828A1
(en)
|
2019-04-08 |
2020-10-15 |
Bard Peripheral Vascular, Inc. |
Medical device with drug-eluting coating on modified device surface
|
US11517457B2
(en)
*
|
2019-07-03 |
2022-12-06 |
Abbott Cardiovascular Systems Inc. |
Intravascular stent
|
TW202134234A
(zh)
*
|
2019-12-05 |
2021-09-16 |
美商奈維特製藥公司 |
雷帕黴素類似物及其用途
|